Myint, Han External Entity

Publications

Sort by

Selected publications

  • Pilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma.  Leukemia & lymphoma2013 Academic Article GET IT
    Times cited: 23

Other